Center for Cancer Nanotechnology Excellence Focused on Therapy Response

Leadership and Organization

Shown here is the organizational structure of our CCNE-TR. The Executive Council, meeting bi-monthly in the first year, will work closely with the IAB to assure the smooth running of this complex program, including careful selection and monitoring of research proposals. The IAB will meet bi-annually. The EAB will be selected by the IAB, should the grant be funded. The EAB will meet annually.

Internal Advisory Board
Russ Altman, MD, PhD Professor, Stanford Genetics	Patrick Brown, PhD Professor, Stanford Biochemistry	Nadeem Ishaque, PhD Manager, GE Health Care Science GE Global Research
Andrew Berlin, PhD Director and General Manager, Intel Corporation Biomedical and Life Sciences	Gary Glazer, MD Professor & Chair, Stanford Radiology	Don Listwin, BS Founder, Canary Foundation
Arthur Bienenstock, PhD Professor, Vice Provost - Dean of Research and Graduate Policy Stanford Materials Science & Engineering	Lee Hartwell, PhD President, Director and Professor, Fred Hutchinson Cancer Institute Human Biology	Mark Sliwkowski, PhD Director Molecular Oncology, Genentech Translational Oncology
Margaret Blohm, PhD Nanotechnology Program Lead, GE Global Research Science & Engineering	Harvey Herschman, PhD Professor, UCLA Johnsson Cancer Center	Irving Weissman, MD Professor Stanford Cancer Center-Pathology